[However, YB-1 may be a candidate for a molecular target in rhabdomyosarcoma therapy, especially in ERMS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations inferred from text-mining the literature.
DisGeNET evidence - LITERATURE